Post Watchman Flx Pro implant with alternative monotherapy regimens
- Trial ID:
- IRB-24-8486
- Matthew J Price, M.D.
Inclusion Criteria
Patients must:
- Be 18 years of age or older.
Be an acceptable candidate for the Watchman Flx Pro device.
Be eligible for all three drug regimens.
Be able to return for required follow-up visits.
Exclusion Criteria
Patients must not:
- Have a contraindication to one of the three protocol defined drug regimens.
Have recurrent deep vein thrombosis, mechanical heart valve, or rheumatic heart disease.
Have chronic kidney disease stage IV or on dialysis.
Be planning to have any cardiac or non-cardiac intervention or surgical procedure within 30 days prior to or 6 months after implant.